We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

First Time Use of SD-809 in Huntington Disease

- Chorea
- Completed

Study Title: First Time Use of SD-809 in Huntington Disease

Teva Identifier: SD-809-C-15

ClinicalTrials.gov Identifier: NCT01795859

Study Status: Completed

Trial Condition(s): Chorea

Interventions: Drug: SD-809 | Drug: Placebo

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

ClinicalTrials.gov study records with inclusion and exclusion criteria

neurology icon for clinical trials

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years and older

Trial Duration: 08/05/2013 - 12/05/2014

Phase: Phase 3

Study Type

Interventional